Talcum Powder Litigation Report
Hot on the heels of separate $72 million and $55 million verdicts entered against Johnson & Johnson defendants, HarrisMartin has launched this Talcum Powder Litigation Report, an online-only resource dedicated solely to news on talc-based powder ovarian cancer claims.
SEARCH THE ARCHIVES
Issue #27, February 2019
U.S. Senator Writes Letter to J&J, ‘Troubled’ by Reports of ‘Alleged Decades-Long Effort’ to Mislead Consumers on Baby Powder Safety
Senator Patty Murray (D-Wash.) has sent a letter to Johnson & Johnson’s Chief Executive Officer, saying she is troubled by the recent reports of an “alleged decades-long effort by Johnson & Johnson to potentially mislead regulators and consumers about the safety of one of its products, which may have resulted in long-term harm for [those] that used Johnson & Johnson baby powder.”
Defendants named in a Florida state court talcum powder action have filed a motion to compel overdue discovery responses from the plaintiffs, arguing that more than four months has passed since written discovery was served.
Issue #26, January 2019
A Pennsylvania state court has stayed a talcum powder action pending the resolution of Imerys Talc America Inc’s interlocutory appeal of an order in which the court agreed to reconsider its earlier determination that it could not exercise jurisdiction over the company.
Parties in Coordinated Calif. Docket for Talcum Powder Claims Agree to Allow Fallopian Tube Cancer Cases
The parties involved in California’s coordinated docket for state talcum powder personal injury claims have agreed to allow cases involving fallopian tube cancer in the docket, according to a recent court document.
Missouri Supreme Court Stays Upcoming Multi-Plaintiff Talcum Powder Trial After Defendants Raise Venue Challenges
The Missouri Supreme Court has sustained a writ of prohibition in an upcoming talcum powder ovarian cancer trial, granting defendants’ request to review a venue dispute in what was scheduled to be the next multi-plaintiff case to proceed to trial in the state.
Johnson & Johnson has moved to stay a talcum powder action brought by the Mississippi Attorney General pending interlocutory appeal of an order denying the defendant’s efforts to obtain summary judgment in the matter.
A Mississippi court has denied a summary judgment motion filed by Johnson & Johnson defendants in a talcum powder action brought by the state’s Attorney General, concluding that there were triable issues of material fact as to whether the defendants hid the risks of developing ovarian cancer from talcum powder use from Mississippi residents.
A Florida appellate court has reversed an order denying Imerys Talc America’s motion to dismiss talc claims asserted against the company on jurisdiction grounds, concluding that the defendant had “no contacts with Florida.”
A Missouri state court has denied Johnson & Johnson’s motion for judgment notwithstanding the verdict, motion for new trials, and motion for new trials on damages in a talcum powder case that ended in a $4.69 billion verdict in favor of 22 talcum powder plaintiffs.
Issue #25, December 2018
Parties in Federal Securities Class Action Against J&J by Stockholders Agree to Lead Counsel, Amended Pleading Deadlines
A New Jersey federal court has signed off on a stipulation submitted by parties in a class action lawsuit filed by Johnson & Johnson stock holders against the company in which the parties outlined deadlines for an amended complaint and motions to dismiss.